National Academies Press: OpenBook

Treating Drug Problems: Volume 1 (1990)

Chapter: Biographical Sketches of Committee Members and Staff

« Previous: References
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 313
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 314
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 315
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 316
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 317
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 318
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 319
Suggested Citation:"Biographical Sketches of Committee Members and Staff." Institute of Medicine. 1990. Treating Drug Problems: Volume 1. Washington, DC: The National Academies Press. doi: 10.17226/1551.
×
Page 320

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Biographical Sketches of Committee Members and Staff LAWRENCE S. LEWIN, chair of the Committee for the Substance Abuse Coverage Study, is president of the Lewin/ICF Health Group, a Washington-based health policy management consulting firm founded in 1970. He has directed a wide range of health policy and strategic planning studies for federal, state, and local governments; academic health centers; hospitals; nursing homes; public foundations; health maintenance organi- zations; insurance companies; and suppliers of services and products to the health care industry. He has also conducted more than 50 workshops for senior state and local health officials, state legislators, and business coali- tion members on a variety of health policy issues. He has helped develop and evaluate programs in the fields of aging, child development, education, and community development. He has chaired and stared a variety of task forces, including the Task Force on Medicaid and Related Programs, of which he was vice chair, and gubernatorial task forces on health care issues in several states. He is a member of the Institute of Medicine. He re- ceived a B.N from the Woodrow Wilson School of Public and International Affairs, Princeton University, and an M.B.N from Harvard University. RAUL CAETANO is a psychiatrist and epidemiologist with the Alco- hol Research Group, Institute of Epidemiology and Behavioral Medicine, Medical Research Institute of San Francisco at Pacific Presbyterian Medical Center, and associate professor in the Department of Social and Adminis- trative Health Sciences, School of Public Health, University of California, 313

314 TREATING DRUG PROBLEMS Berkeley. He was previously the recipient of fellowships from the Brazil- ian Ministry of Education, the Pan American Health Organization, and the Medical Council on Alcoholism Research. He has been involved in a wide range of epidemiological studies in the psychiatric and substance abuse fields. His research has focused on the relationship between ethnicity and substance abuse, especially among U.S. Hispanics, and on conceptual issues associated with the diagnosis of alcohol dependence. He has been an adviser to the Pan American Health Organization and university and government institutions throughout Latin America. He is a member of the American College of Epidemiology, the American Public Health Associa- tion, and the Brazilian Psychiatric Association. He received an M.D. from the School of Medicine, Rio de Janeiro State University, and an M.P.H. and Ph.D. from the School of Public Health, University of California, Berkeley. DAVID ~ COURTWRIGHT is professor and chair of the Department of History at the University of North Florida. He has also been a faculty member at the University of Hartford, the University of Connecticut Health Center, and the University of Texas School of Public Health. He has received fellowships from the University of Texas Medical Branch, the Samuel E. Ziegler Educational Foundation, and the National Endowment for the Humanities. He is a member of the American Historical Association and the Organization of American Historians. His publications include Dark Paradise: Opiate Addiction in America Before 1940 and Addicts Who Survived: An Oral History of Narcotic Use in Amenca, 1923-1965. He received a B.N from the University of Kansas and a Ph.D. from Rice University. DAVID A. DEITCH, a clinical and social psychologist, is vice president and chief executive officer for field operations at Daytop Village, Inc., a nonprofit drug and alcohol treatment agency with facilities in New York, California, and Texas. He is also director of clinical and organizational consultation, Pacific Institute for Clinical Staining, Education, and Con- sultation, Berkeley, California. He was previously executive director and cofounder of Daytop Village, senior vice president and chief clinical offl- cer of Phoenix House Foundation, and chief of substance abuse services, University of California, San Francisco. He has also been a clinical faculty member in departments of psychiatry at the University of California, San Diego; the University of Chicago; and Temple University. He was chairman of the White House Task Force on Prevention, a consultant to the Presi- dential Commission for the Study of Crime and Juvenile Delinquency and the National Commission on Marijuana and Drug Abuse, and a member of the Pennsylvania Governor's Council on Alcohol and Drug Abuse. He received the state of California award for outstanding contributions in the

Bl~HIC~ SKETCHES OF COMM~EE MEMBER ID STIFF 315 drug abuse field. He received his M.S. and Ph.D. from the Wright Institute, Berkeley, California. DOUGLAS A. FRASER is professor of labor studies at Wayne State University. He was the Jerry Wurf Fellow and Lecturer at the John F. Kennedy School of Government, Harvard University. He is retired from the United Auto Workers, where he served as vice president and president. First appointed to the staff of the UAW in 1947, he concentrated much of his energy on negotiating and implementing employee benefit programs. He was responsible for the union's early retirement program, restrictions on compulsory overtime, a comprehensive health and safety program, dental care benefits, reduced work time, and improvements in the cost-of-living allowance formula. He has served as cochair of the Michigan Governor's Commission on Jobs and Economic Development and as a member of the board of trustees of the Aspen Institute for Humanistic Studies and the Executive Committee of the Leadership Conference on Civil Rights and as a member of the board of governors of the United Way. JAMES G. HAUGHTON is medical director of the Martin Luther King, Jr./Charles R. Drew Medical Center of the Los Angeles County Department of Health Services. After serving in leading public health positions with the New York City Health and Welfare Departments, he served for nine years as the executive director for the Health and Hospitals Governing Commission in Chicago and subsequently as director of the Department of Health and Human Services, City of Houston. He is currently a member of the advisory board of the Robert Wood Johnson Foundation AIDS health service programs and the board of directors of the Alan Guttmacher Institute. He has received awards from the National Association of Health Services Executives, the March of Dimes, and the Los Angeles Board of Supervisors. He is a fellow of the American College of Preventive Medicine and the American Public Health Association, and a member of the American Medical Association, National Medical Association, Southern Medical Association, Texas Medical Association, United States Conference of Human Services Officials, and the United States Conference of Local Health Officials. He is a member of the Institute of Medicine. He received a B.N from Pacific Union College, an M.D. from Loma Linda University, and an M.P.H. from Columbia University School of Public Health and Administrative Medicine. ROBERT ~ HUBBARD is a social psychologist and program director for alcohol and drug abuse research in the Center for Social Research and Pol- icy Analysis, Research Triangle Institute, North Carolina. He was principal investigator for the Treatment Outcome Prospective Study follow-up of a large multicity sample of drug treatment clients, and he is the lead author

316 TREATING DRUG PROBLEMS of Snug Abuse Treatment. He has completed studies on adult and teenage drug use epidemiology; the relationships among drug use, employment, and crime; assessment of vocational services in drug treatment programs; and management styles and occupational programs in industry. He is currently directing a study of substance abuse prevention for high-risk youth and a methodological study of client self-reports after treatment, among other drug research studies at the Research Triangle Institute. He was previously at the Survey Research Center, University of Michigan. He is a member of the American Association for Public Opinion Research, American Psycho- logical Association, American Public Health Association, American Society of Criminology, American Sociological Association, and the American Sta- tistical Association. He received a B.N from Ohio University, a Ph.D. from the University of Michigan, and an M.B.N from the Fuqua School of Business, Duke University. JAMES D. ISBISTER is president of Pharmavene, Inc. His career in government from 1962 to 1977 included service as the administrator of the Alcohol, Drug Abuse, and Mental Health Administration. He has been vice president of the Orkand Corporation, associate director for management of the International Communication Agency, senior vice president of the Blue Cross and Blue Shield Association, and president of Combined Technologies, Inc. He has received the William ~ Jump Foundation Award for exemplary achievement in public administration, the Arthur S. Flemming Award, and numerous other commendations. He received a B.N from the University of Michigan and an M.N from George Washington University. HERBERT D. KLEBER is on leave as professor of psychiatry at Yale University School of Medicine where he is founding director of the Sub- stance Abuse Treatment Unit at the Connecticut Mental Health Center. He is also director of Yale's Center for Opioid and Cocaine Abuse Treatment Research and chief executive officer of APT Foundation, Inc. He served on the Governor's Drug Advisory Council (Connecticut) and cochaired the Mayor's Task Force on Drugs (New Haven). He has received the Ameri- can Psychiatric Association Gold Award, the Foundations Fund Award for Research, and the Founders Award of the American Academy of Psychia- trists in Alcoholism and Addiction (AAPAA). He previously served on the national advisory councils of the National Institute on Drug Abuse and the National Institute of Mental Health. He is a fellow of the American Psychi- atric Association and the American College of Neuropsychopharmacology, a member of the American Medical Association, and a founding member of AAPAA He received a B.N from Dartmouth College and an M.D. from Jefferson Medical College, serving a psychiatric residency at Yale. In

Bl~HIC~ SKETCHES OF COMMITTEE MEMBER AD STAFF 317 August 1989 he was confirmed by the U.S. Senate as deputy director for demand reduction in the Office of National Drug Control Policy. JUDITH R LAVE is professor of health economics at the Graduate School of Public Health, University of Pittsburgh. She has also taught economics and urban affairs at Carnegie Mellon University and was director of the Office of Research, Health Care Financing Administration, U.S. Department of Health and Human Services. She is a member of the American Economic Association, the American Public Health Association, and the Association for Health Services Research, which she served as president. She is a member of the Institute of Medicine. She received a B.N from Queen's University and an M.N and Ph.D. from Harvard University. DAVID ~ MACTAS, a certified addictions specialist and social worker, is president of Marathon, Inc., a nonprofit drug and alcohol treatment and research agency based in Providence, Rhode Island. He was previously on the staff of the Morris J. Bernstein Institute, St. Vincent's Medical Center, and the Vera Institute of Justice, all in New York City, and he served as assistant commissioner of the New York City Addiction Services Agency. He has taught at Rhode Island College and New England Institute of Technology. He served as president of Therapeutic Communities of America and is a board member of the World Federation of Therapeutic Communities. He received a B.N from City College of New York and an M.N from the New School for Social Research. DONALD ~ McCONNELL is executive director of the Connecticut ~- cohol and Drug Abuse Commission. He has previously been a priest with the Archdiocese of Newark, New Jersey; an educational consultant with the Institutes for Rural Education, Santiago, Chile; director of Latin Amer- ican Studies at Seton Hall University; director of education and training, State of New Jersey Drug Abuse Project; and director of addiction ser- vices, Connecticut Department of Corrections. He was the recipient of the National Association of State Alcohol and Drug Abuse Directors' award for outstanding leadership and dedication, the Alcohol and Drug Prob- lems Association award for outstanding achievement for an individual, the Nyswander/Dole award for contributions to the field of methadone main- tenance, and the Connecticut Hispanic Addiction' Commission award for dedication to the recovery of Latino substance abusers. He is a member of the Alcohol and Drug Problems Association; the Advisory Council on AIDS of the National Institute on Drug Abuse; and the National Asso- ciation of State Alcohol and Drug Abuse Directors, which he has served as president. He received a B.N from Seton Hall University, an M.Div.

318 TREATING DRUG PROBLEMS from Immaculate Conception Seminary, and two M.N degrees and a Ph.D. candidate certificate from the University of Wisconsin at Madison. JOHN H. MOXLE~ III is vice president and partner at Korn/Ferry In- ternational, where he conducts nationwide searches for physician executives sought by organizations in the private and public sectors. Before joining Korn/Ferry, he had his own consulting practice focusing on organizational issues in health care. His prior experience includes positions as senior vice president of American Medical International, Inc.; assistant secretary of defense for health affairs in the Department of Defense; vice chancellor and dean of medicine at the University of California, San Diego; dean of the University of Maryland School of Medicine; and assistant to the dean of Harvard Medical School. In 1984, he served as director of Polyclinic Health Services for the XXIII Olympics. He has served on the board of trustees of the American Hospital Association and chaired the scientific board and served on the governing council of the California Medical Association. He currently selves on the board of the National Fund for Medical Education and the Henry M. Jackson Foundation for the Advancement of Military Medicine. He is board-certified in internal medicine and is a fellow of the American College of Physicians and a distinguished fellow of the American College of Physician Executives. He is a member of the Association of American Medical Colleges, the Society of Medical Administrators, and the American Society of Clinical Oncology. He is a member of the Institute of Medicine. He received an NB. from Williams College and an M.D. from the University of Colorado. PETER S. O'DONNELL is a partner and cofounder of the KEREN Group, a health care management and marketing firm based in Princeton, New Jersey. He has previously been the president and chief executive offi- cer of a regional managed care health plan with more than 20,000 members and 1,400 physicians under contract. Prior to that he was senior vice pres- ident of ALTA Health Strategies, Inc., a major third-party administrator of health benefits, where he developed and implemented utilization review programs and related managed care programs. He was previously director of employee benefits for the RCA Corporation; a consultant for the Wm. Mercer Company, a national health benefits consulting firm; senior health adviser to the governor of Florida; staff associate with the National Gover- nors' Association; and a member of the staff of the Advisory Commission on Intergovernmental Relations. He is a member of the editorial board of Managed Care Outlook and selves on the board of the Alpha Center and the Foundation for Health Services Research. He received a B.N from the Pennsylvania State University and an M.N from Rutgers University.

Bl~HIC~ SKETCHES OF COMMITTEE MEMBER ED STAFF 319 MARK V. PAULY is professor of health care systems and public man- agement at the Wharton School, director of research of the Leonard Davis Institute of Health Economics, and professor of economics at the Uni- versity of Pennsylvania. His major interests are public finance, collective decision making, insurance regulation, and medical economics. He serves on the health advisory board of the American Enterprise Institute, where he has been an adjunct scholar, and he has also been a board member of the Association for Health Services Research. He has held fellowships at the International Institute of Management (Berlin) and the International Institute for Applied Systems Analysis (Vienna). He has been a faculty research fellow at the National Bureau of Economic Research, professor of economics at Northwestern University, and a research associate with the U.S. Public Health Service. He is a member of the American Economic Association and the Association for Health Services Research. He is a member of the Institute of Medicine. He received an AB. from Xavier University, an M.N from the University of Delaware, and a Ph.D. from the University of Virginia. HAROLD A. RICHMAN is director of Chapin Hall Center for Children and Hermon Dunlap Smith Professor in the School of Social Service Ad- ministration, University of Chicago. His earlier positions at the University of Chicago include dean of the School of Social Service Administration, founding chairman of the Committee on Public Policy Studies, and codi- rector of the children's policy research project. He was previously a White House fellow and special assistant to the secretary of labor. He is cur- rently on the board of the University of Chicago Laboratory Schools and is a member of the executive management committee, National Opinion Research Center. He chairs the research advisory committee on youth of the Lilly Endowment, Inc., and the Children's Program Committee of the Edna McConnell Clark Foundation; he is also a member of numerous non- profit boards and advisory committees. He received an JOB. from Harvard College and a Ph.D. in social welfare policy from the University of Chicago. MAXINE ~ STITZER is associate professor of behavioral biology in the Department of Psychiatry and Behavioral Sciences, Johns Hopkins Univer- sity School of Medicine, and associate director of the drug abuse treatment research unit at Francis Scott Key Medical Center. She has been active in drug abuse research with areas of specialization in human behavioral phar- macology and substance abuse treatment evaluation. She serves as editorial consultant for several scientific journals and was previously a member of the clinicalJbehavioral research review committee of the National Institute on D-rug Abuse. She is a fellow of the American Psychological Association and a member of the Behavioral Pharmacology Society, American Public Health Association, and Society for Behavioral Medicine. She received a

320 TREATING DRUG PROBLEMS B.N from the University of California, Berkeley, and an M.S. and Ph.D. from the University of Michigan. DEAN R GERSTEIN, a sociologist, is a study director at the Institute of Medicine and National Research Council of the National Academy of Sci- ences, where his earlier studies include Alcohol and Public Policy: Beyond the Shadow of Prohibition, Commonaliaes in Substance Abuse and Habitual Behavior, Guidelines for Studies on Substance Abuse Treatment, and The Be- havioral and Social Sciences: Achievements and Opportunities. He has done research on addiction careers, drug treatment programs, alcohol and high- way crashes, smoking and mortality, and the development of social theory and held editorial positions with Contemporary Drug Problems and Sociolog- ical Theory. Previously, he was at the University of California, Los Angeles, the University of California, San Diego, and the Veterans Administration Medical Center, La Jolla. He is a member of the American Sociological Association, the American Public Health Association, the Kettil Bruun Society for Sociological and Epidemiological Research on Alcohol, and the Alcohol and Drug Study Group of the American Anthropological Associ- ation. He received a B.N from Reed College and a Ph.D. from Harvard University. HENRICK ~ ROOD, an economist, served as associate study di- rector for the Substance Abuse Coverage Study. Prior to joining the staff of the Institute of Medicine, he was at the Research Triangle Institute in North Carolina, where he was the principal author of Economic Costs of Alcohol and Drug Abuse and Mental Illness—1980 and contributed the economic analyses used in the Department of Health and Human Services' report to Congress, Toward a National Plan to Combat Alcohol Abuse and Alcoholism. He has done research on the impact of alcohol and drug consumption on productivity in the work force, the crime-related costs and benefits of different modalities of drug treatment, and the provision of em- ployment seIvices and vocational services in drug treatment programs. He has held adjunct faculty appointments at Erasmus University in Rotterdam, the Netherlands, and Duke University. He received a B.N from Stetson University and performed graduate studies in economics at the University of North Carolina, Chapel Hill. In December 1989 he accepted the position of senior policy analyst in the Office of National Drug Control Policy.

Next: Index »
Treating Drug Problems: Volume 1 Get This Book
×
Buy Hardback | $70.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The large federal role in the drug treatment system was substantially reduced in the early 1980s, undercutting its ability to help communities respond to new challenges such as the crack-cocaine epidemic and the growing violence in drug markets.

How can drug treatment dollars be spent most equitably with the highest likelihood of beneficial results? With this basic question as its focus, Treating Drug Problems, Volume 1 provides specific recommendations on how to organize and fund the drug treatment system. Detailed attention is given to both public and private sources and their programs.

The book presents the latest data and analysis on these topics and more:

  • How specific approaches to drug treatment fit into drug policy, including the different perspectives of the medical and criminal-justice communities.
  • What is known about drug consumption behavior and what treatment approaches have proven most cost-beneficial.
  • What areas need further research—including specifications for increased study of treatment effectiveness and drug use by adolescents and young women.
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!